Oruka Therapeutics, Inc. · NASDAQ:ORKA

Klein Lawrence Otto sold 1,729 Oruka Therapeutics, Inc. shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 15, 2026

On Jun 15, 2026, Klein Lawrence Otto (Director, Chief Executive Officer) sold 1,729 Oruka Therapeutics, Inc. shares at US$69.69 for US$120K, leaving 925,580 shares. Filed Jun 15, 2026 (Form 4).

Sold
1,729 shares
Price
US$69.69
Value
US$120K
Holding after
925,580 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockSale1,729US$69.69925,580Direct

Source

View original at SEC

Related